Category: us corporate news

us corporate news

Cullinan Therapeutics Reports 2025 Financial Results, Updates on CLN-978, Zipalertinib NDA, and 2026 Clinical Milestones

Minichart

March 10, 2026

Cullinan Therapeutics Corporate Update and FY2025 Financial ...

Continue Reading 0

us corporate news

Horizon Quantum Computing Achieves Key Milestones, Secures $111.9M PIPE Financing, and Advances Quantum Software Ahead of dMY Merger 123

Minichart

March 10, 2026

Horizon Quantum and dMY Announce Significant Milestones Ahea...

Continue Reading 0

us corporate news

Harvard Bioscience Amends Executive Employment Agreements for CEO John Duke and CFO Mark Frost – Key Terms and Provisions

Minichart

March 10, 2026

Harvard Bioscience, Inc. Announces Executive Employment Agre...

Continue Reading 0

us corporate news

NextEra Energy, Inc. SEC Filing: Common and Corporate Units Listed on NYSE – Regulatory Filing Details

Minichart

March 10, 2026

NextEra Energy 8-K Report: Executive Resignation NextE...

Continue Reading 0

us corporate news

Soluna Holdings Monthly Update: Bitcoin Mining Expansion, AI Data Center Developments, and Renewable Energy Projects (February 2026)

Minichart

March 10, 2026

Soluna Holdings, Inc. (Nasdaq: SLNH) February 2026 Business ...

Continue Reading 0

us corporate news

Tenax Therapeutics Achieves Phase 3 LEVEL Study Patient Target and Reports 2025 Financial Results; Topline Data Expected Q3 2026

Minichart

March 10, 2026

Tenax Therapeutics Achieves Key Milestones in Phase 3 Trials...

Continue Reading 0

us corporate news

SAB Biotherapeutics Announces Positive Phase 1 Results for SAB-142 Showing C-Peptide Preservation in Adult Type 1 Diabetes Patients

Minichart

March 10, 2026

SAB Biotherapeutics Reports Encouraging Phase 1 Data for SAB...

Continue Reading 0

us corporate news

ADC Therapeutics SA Files 8-K Report Detailing Company Information and Common Shares Listing on NYSE

Minichart

March 10, 2026

ADC Therapeutics SA - 2025 Year-End Financial Results Analys...

Continue Reading 0

us corporate news

Galecto Changes Name to Damora Therapeutics, Advances mutCALR Antibody Pipeline for Blood Disorders and Secures $535M Funding 1

Minichart

March 10, 2026

Damora Therapeutics (formerly Galecto) Announces Name Change...

Continue Reading 0

us corporate news

Signing Day Sports and BlockchAIn Digital Infrastructure Announce Anticipated NYSE American Listing After Business Combination Closing on March 16, 2026 1

Minichart

March 10, 2026

Signing Day Sports Announces Anticipated Closing Date for Bu...

Continue Reading 0